Reviewing the serotonin reuptake inhibitors (SSRIs) footprint in the aquatic biota: uptake, bioaccumulation and ecotoxicology

Environ Pollut. 2015 Feb:197:127-143. doi: 10.1016/j.envpol.2014.12.002. Epub 2014 Dec 18.

Abstract

Selective serotonin re-uptake inhibitors (SSRIs) antidepressants are amongst the most prescribed pharmaceutical active substances throughout the world. Their presence, already described in different environmental compartments such as wastewaters, surface, ground and drinking waters, and sediments, and their remarkable effects on non-target organisms justify the growing concern about these emerging environmental pollutants. A comprehensive review of the literature data with focus on their footprint in the aquatic biota, namely their uptake, bioaccumulation and both acute and chronic ecotoxicology is presented. Long-term multigenerational exposure studies, at environmental relevant concentrations and in mixtures of related compounds, such as oestrogenic endocrine disruptors, continue to be sparse and are imperative to better know their environmental impact.

Keywords: Bioaccumulation; Ecotoxicology; Environmental contaminants; Selective serotonin re-uptake inhibitors; Uptake.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aquatic Organisms / drug effects
  • Aquatic Organisms / metabolism*
  • Biota
  • Ecotoxicology
  • Environment
  • Environmental Pollutants
  • Selective Serotonin Reuptake Inhibitors / analysis
  • Selective Serotonin Reuptake Inhibitors / metabolism*
  • Selective Serotonin Reuptake Inhibitors / toxicity
  • Water Pollutants, Chemical / analysis
  • Water Pollutants, Chemical / metabolism*
  • Water Pollutants, Chemical / toxicity

Substances

  • Environmental Pollutants
  • Serotonin Uptake Inhibitors
  • Water Pollutants, Chemical